Back

Empagliflozin reduces the doxorubicine-induced myocardial dysfunction.

26 August 2017 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Best Posters 5 - Best Posters in comorbidities in heart failure Ventricular function / haemodynamics ESC Premium Access ESC Congress 2017

About the speaker

Photo
Doctor Jolanda Sabatino

Magna Graecia University of Catanzaro, Catanzaro (Italy)

4 More presentations in this session

Presentation thumbnail
Best Posters in comorbodities in heart failure
Presentation thumbnail
Acute treatment of levosimendan attenuates chronic doxorubicin-induced cardiomyopathy in vivo: implication of the critical role of inotropic action
Doctor P. Efentakis (Athens, GR)
Abstract Slides
Presentation thumbnail
Cardiorenohepatic syndrome reflects severity of decompensated heart failure and is related with worse prognosis
Associate Professor A. Soloveva (Saint Petersburg, RU)
Abstract Slides
Presentation thumbnail
Iron deficiency predicted hospitalizations in elderly patients with symptoms of heart failure
Mrs M. Olofsson (Skelleftea, SE)
Abstract Slides

Access the full session

Session thumbnail
Best Posters 5 - Best Posters in comorbidities in heart failure

The Event

Event poster

ESC Congress 2017

26 August - 30 August 2017

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources